🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06619379
Active, not recruiting Not applicable

The Effect of Vaginal Speculum Type and Retention Time on Pregnancy Outcomes During The Embryo Transfer Process

NCT06619379 · tracked via the Priya Life Science Turkey tracker
Sponsor
Eurofertil IVF Health Center
Phase
Not applicable
Started
2025-06-17
Last updated
2025-07-25

Condition(s) studied

Pregnancy Rates

Investigational drug(s) / intervention(s)

Retention time of speculum

Retention time of speculum: According to the randomization, the speculum can be extracted : 1. just after the transfer catheter is withdrawn 2. 60 seconds after the transfer catheter is withdrawn 3. 420 second (7 minutes) after the catheter is withdrawn

Study summary

Investigators aim to investigate possible affects of a speculum material and retention strategy on IVF pregnancy results. The study is planned as a prospective, randomized control trial. All of the clinical managements, including the embryo transfers, will be performed by the same gynecologist for homogeneity of the study. Only the cases with good implantation potentials are going to be included. Therefore, transfers with cleavage embryos and blastocysts rather than good and top quality will be excluded. All patients included to final statistical analysis will receive the same luteal support.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * women aged 20-40 * cases that good and top quality embryos are achieved for embryo trasnfer Exclusion Criteria: * recurrent implantation failure * any known genetic problems of couple * any known mullein anomalies * PGT-A cases * thin endometrium

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Eurofertil Bursa Turkey (Türkiye)

More Eurofertil IVF Health Center trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06619379 on ClinicalTrials.gov ↗ ← All trials in Turkey